{
  "title": "M21-1, Part V, Subpart iii, Chapter 11 - Endocrine Conditions",
  "url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180518/M21-1-Part-V-Subpart-iii-Chapter-11-Endocrine-Conditions",
  "content": "<-- Previous Section\nNext Section -->\nOverview\nIn This Chapter\nThis chapter contains the following topics:\nTopic\nTopic Name\n1\nDiabetes Mellitus\n2\nComplications of Diabetes Mellitus\n3\nThyroid Conditions\n4\nExamples of Rating Decisions Involving the Complications of Diabetes Mellitus\n1\n.\nDiabetes Mellitus\nIntroduction\nThis topic contains information about diabetes mellitus, including\ndefinition of diabetes mellitus\nsymptoms of diabetes mellitus\nevaluating diabetes mellitus\nsuccessive criteria requirement for the next higher disability evaluation\ninformation on regulation of activities\nscope of diabetes mellitus claims\nrequesting examinations for diabetes mellitus or diabetic complications\nfailure to report in claims for increase in diabetes mellitus,\nand\neffective dates for\nservice connection (SC) of diabetes mellitus\n, and\nclaims for increase of diabetes mellitus\n.\nChange Date\nJune 6, 2024\nV.iii.11.1.a\n.\nDefinition: Diabetes Mellitus\nDiabetes mellitus\nis a metabolic disorder in which the body is unable to use glucose (a type of sugar obtained from food) effectively.  Hyperglycemia, an abnormally high level of blood sugar, results.\nDiabetes mellitus is not seriously disabling if, on a diet sufficient to maintain the weight and strength of the claimant, the\nblood glucose can be kept within normal limits, and\nurine is absent glucose.\nAs diabetes mellitus progresses\nit becomes more difficult to control, even with insulin\ncomplications develop which increase the degree of disability, and\nincreasing limitation of activity due to unstable blood sugar levels limits employability.\nV.iii.11.1.b\n.\nSymptoms of Diabetes Mellitus\nThe cardinal symptoms of uncontrolled diabetes mellitus are\npolyuria (excessive urination)\npolydipsia (excessive thirst)\npolyphagia (excessive hunger)\nweakness, and\nloss of weight.\nThe presence of sugar in the urine is characteristic of, but not essential to, a diagnosis of diabetes mellitus.\nNotes\n:\nA diagnosis of diabetes mellitus cannot be made from glycosuria alone, as this may result from\na low renal threshold for sugar, or\nexcessive ingestion of sugar.\nPersistent hyperglycemia, a blood sugar of 170 milligrams (mg) per 100 cubic centimeters (ccs) blood after 12-hour fast, and glycosuria may be related to\nhyperthyroidism\ndyspituitarism\npregnancy\napoplexy\ncerebral trauma, or\nsevere infections.\nV.iii.11.1.c\n.\nEvaluating Diabetes Mellitus\nEvaluations of diabetes mellitus are assigned under\n38 CFR 4.119, diagnostic code (DC) 7913\n.  The diagnostic criteria take into account\nthe means necessary to control diabetes, specifically\nrestricted diet\noral hypoglycemic agent\none or more daily injection of insulin, and\nregulation of activities\nfrequency of specific types of care for episodes of ketoacidosis or hypoglycemic reactions\nhospitalizations, or\nvisits to a diabetic care provider\nprogressive loss of weight and strength, and\ndiabetic complications.\nNote\n:  To treat diabetes mellitus, medical providers may prescribe non-insulin injectable medications, such as Ozempic, Victoza, Trulicity, or other generic versions.  These medications are distinctly different from injectable insulin.  Like oral hypoglycemic agents, non-insulin injectable medications help lower blood glucose levels.  For rating purposes, evaluate a prescription for a non-insulin injectable medication in the same manner as a prescription for an oral hypoglycemic agent.  Do\nnot\nconsider a non-insulin injectable medication as equivalent to treatment with insulin.\nReferences\n:  For more information on\nevaluating complications of diabetes mellitus, see\nM21-1, Part V, Subpart iii, 11.2.b\n, and\nscope of diabetes mellitus claims, see\nM21-1, Part V, Subpart iii, 11.1.f\n.\nV.iii.11.1.d\n.\nSuccessive Criteria Requirement for the Next Higher Disability Evaluation\nWhen determining the appropriate disability evaluation to assign for diabetes mellitus, note that the criteria are successive.  This means the Veteran can\nonly\nbe rated at the next higher disability evaluation when all criteria at the lower disability evaluation are met plus element(s) specific to the higher evaluation are satisfied.\nReferences\n:  For more information on\ndiabetes mellitus, see\n38 CFR 4.119, DC 7913\n, and\nCamacho v. Nicholson\n, 21 Vet.App. 360 (2007), and\nrelationships within evaluation criteria, see\nM21-1, Part V, Subpart ii, 3.D.2.a\n.\nV.iii.11.1.e\n.\nInformation on Regulation of Activities\nThe term\nregulation of activities\nis defined parenthetically in\n38 CFR 4.119, DC 7913\nto mean the requirement of “avoidance of strenuous occupational and recreational activities.”  In turn, this must be understood as meaning that the avoidance is\nrequired\nto help control blood sugar.\nVoluntary avoidance of strenuous activity by the Veteran, undertaken with the intention of avoiding hypoglycemic episodes, does\nnot\nmeet the regulatory criteria.  Evidence must document that the avoidance of strenuous activities is required/prescribed as part of medical management of the individual’s diabetes.\nPrescribed or voluntary exercise also does not satisfy the regulation-of-activities criterion.\nNotes\n:\nWhich specific activities are medically contraindicated as strenuous (what medical restrictions have been prescribed) is a factual medical question.\nThe\nDiabetes Mellitus\nDisability Benefits Questionnaire\n(DBQ) requires that the examiner address whether avoidance of strenuous occupational and recreational activities to avoid hypoglycemic episodes is required as part of medical management of diabetes mellitus, and if so, to provide examples.\nThe conclusion that “regulation of activities” is demonstrated is an adjudicative determination.\nIt is the Department of Veteran’s Affairs (VA’s) policy to concede that an individual’s diabetes mellitus requires insulin, restricted diet, and regulation of activities when the diabetes has caused episodes of ketoacidosis that have resulted in hospitalization.\nV.iii.11.1.f\n.\nScope of Diabetes Mellitus Claims\nAs discussed in\nM21-1, Part V, Subpart ii, 3.A\n, determining what issues are within scope of a claim is a case-by-case determination based on a sympathetic reading of the evidence.\nWhen reviewing claims for diabetes mellitus, including diabetic complications, consider whether the evidence establishes entitlement to\nan increased evaluation for the\ndiabetes mellitus, and/or\nservice-connected (SC) complication(s), and/or\nservice connection (SC) for expressly claimed or newly discovered, unclaimed complications.\nNotes\n:\nAs complications of diabetes mellitus are part of the evaluation criteria for the disease, entitlement to any additional benefits based on complications would be considered within scope of the claim.\nFollow the guidance in\nM21-1, Part V, Subpart ii, 3.A.2.c\nfor handling complications of an expressly claimed issue, including when to obtain adequate medical evidence, such as an examination.\nReferences\n:  For more information on\nclaim requirements and scope of claim, see\n38 CFR 3.155\nclarifying issues and claims, see\nM21-1, Part III, Subpart i, 2.D.1.c\n, and\naddressing unclaimed hypertension as a complication of diabetes mellitus, see\nM21-1, Part V, Subpart iii, 11.2.f\n.\nV.iii.11.1.g\n.\nRequesting Examinations for Diabetes Mellitus or Diabetic Complications\nRefer to the table below for general guidance on determining which examinations to request in claims for diabetes mellitus or diabetic complications.\nIf the claim wording is interpreted as requesting compensation for ...\nThen request ...\ndiabetes mellitus (initial SC or an increased evaluation) with or without complications specified\nthe\nDiabetes Mellitus Disability Benefits Questionnaire\n, when necessary to decide the claim.\nImportant\n:\nIf the Veteran explicitly claims a diabetic complication (new or increased evaluation), or is already SC for a complication(s), include a comment in the examination request to alert the examiner.\nThe\nDiabetes Mellitus Disability Benefits Questionnaire\nmust address all diabetic complications present, to include completion of additional DBQs as appropriate.\nIf the examiner fails to address all diabetic complications and complete all necessary DBQs, the examination must be returned as insufficient.\na specified diabetic complication(s) (new or an increased evaluation)\nthe specific DBQ(s) associated with the claimed complication(s), when necessary to decide the claim.\nNote\n:  Do\nnot\nrequest the\nDiabetes Mellitus Disability Benefits Questionnaire\n.\nImportant\n:  Worsening of a diabetic complication could indicate a broader worsening of the diabetes generally.  When worsening in the diabetic process is shown, follow procedures for deciding all issues within scope of the claim as outlined in\nM21-1, Part V, Subpart iii, 11.1.f\n, and\nM21-1, Part V, Subpart ii, 3.A.2.c\n.\nReferences\n:  For more information on\nwhen an examination is necessary to decide a claim, see\nM21-1, Part IV, Subpart i, 1.A\nand\nB\n, and\ndeveloping for a relationship between diabetes mellitus and hypertension, see\nM21-1, Part V, Subpart iii, 11.2.g\n.\nV.iii.11.1.h\n.\nFailure to Report in Claims for Increase in Diabetes Mellitus\nSee the table below for guidance on the correct rating action to take when a claimant fails to report for a necessary VA examination in connection with a claim for increase for diabetes mellitus.\nIf the claim ...\nThen ...\nis limited to an increase in one or more separately evaluated diabetic complications\ndeny an increase for the claimed complication(s) based on failure to report for the examination without good cause.\nException\n:  If the other evidence of record is sufficient to address the evaluation criteria for the claimed complication(s), issue a grant or denial as supported by that evidence.\nexpressly refers to a reevaluation or increase for diabetes mellitus, whether or not it mentions complications\ndeny\nan increase in the evaluation for the diabetic process, and\nany expressly claimed diabetic complications.\nException\n:  Evaluate the evidence of record in accordance with\n38 CFR 3.326\nto determine if it is otherwise adequate for rating purposes without a VA examination.  If it is, make a decision based on that evidence.\nReference\n:  For more information on failure to report for examinations in connection with a claim for an increased evaluation, see\n38 CFR 3.655(b)\n.\nV.iii.11.1.i\n.\nEffective Dates for SC of Diabetes Mellitus\nFor SC of diabetes, the effective date is generally the later of the date of claim or date entitlement arose.  This includes the effective date for\nany evaluation of the diabetic process, and\nany separate evaluation of diabetic complications.\nImportant\n:  Consider entitlement to an earlier effective date, when applicable, under\n38 CFR 3.114\nand the\nNehmer\nstipulation.\nReferences\n:  For more information on\nassignment of effective dates for SC, see\n38 CFR 3.400\neffective dates for diabetic complications, see\nM21-1, Part V, Subpart iii, 11.2.c\n, and\nthe\nNehmer\nstipulation, see\nM21-1, Part VIII, Subpart i, 2\n.\nV.iii.11.1.j\n.\nEffective Dates for Claims for Increase of Diabetes Mellitus\nUnder\n38 CFR 3.400(o)\n, assign increased evaluations of diabetes mellitus from\nthe date an ascertainable increase in the disability occurred if a complete claim or intent to file a claim is received within one year from such date, otherwise\ndate of receipt of claim.\nNotes\n:\nPrior to March 24, 2015,\n38 CFR 3.157\nwas in effect.  Under that regulation, certain records showing treatment could be considered claims for increase.\nEffective March 24, 2015, claims must be filed on standard forms and records are no longer treated as claims for increase.\nDevelopment of new diabetic complications is evidence of an ascertainable increase in the diabetic process.\nReferences\n:  For more information on\neffective dates for diabetic complications, see\nM21-1, Part V, Subpart iii, 11.2.c\nhistorical treatment of treatment records as claims, see\n38 CFR 3.157\ninformal claims received prior to March 24, 2015, see\nM21-1, Part II, Subpart iii, 2.H\nintent to file, see\nM21-1, Part II, Subpart iii, 2.A\nrequests for application, see\nM21-1, Part II, Subpart iii, 2.G\n, and\nhow to file a claim, see\n38 CFR 3.155\n.\n2\n.\nComplications of Diabetes Mellitus\nIntroduction\nThis topic contains information about complications of diabetes mellitus, including\ncommon complications of diabetes mellitus\nevaluating complications of diabetes mellitus\neffective date for diabetic complications\ncardiovascular complications of diabetes mellitus\nwhen evidence supports that hypertension is or is not a complication of diabetes mellitus\naddressing unclaimed hypertension as a complication of diabetes mellitus\ndevelopment on the relationship between diabetes mellitus and hypertension\nneurological complications of diabetes mellitus\nophthalmological complications of diabetes mellitus\ngenitourinary complications of diabetes mellitus\nmusculoskeletal complications of diabetes mellitus\nimmune and other miscellaneous complications of diabetes mellitus\n, and\nskin complications of diabetes mellitus\n.\nChange Date\nNovember 29, 2016\nV.iii.11.2.a\n.\nCommon Complications of Diabetes Mellitus\nAs noted in\nM21-1, Part V, Subpart iii, 11.1.a\n, complications are disabilities of various body systems, including but not limited to the following, caused by progression of diabetes:\ncardiovascular\nneurological\nophthalmological\ngenitourinary\ngynecological\nmusculoskeletal\nimmune, and\nskin.\nNotes\n:  Once diabetic complications begin, multiple complications are usually considered or involved.\nReference\n:  For more information on scope of claim and examination requirements in claims for diabetes mellitus, see\nM21-1, Part V, Subpart iii, 11.1.f\nand\ng\n.\nV.iii.11.2.b\n.\nEvaluating Complications of Diabetes Mellitus\nPer\n38 CFR 4.119, DC 7913\n, evaluate compensable complications of diabetes mellitus separately unless they are a part of the criteria used to support a 100-percent evaluation.\nNoncompensable complications are considered part of the diabetic process under\n38 CFR 4.119, DC 7913\n.\nBefore conceding that a particular disability is a complication of diabetes, ensure that there is medical evidence of record supporting that determination.  In some cases, a particular disability of a body part of system could be a diabetic complication or it could be due to another cause.  For example, neurological symptoms in the lower extremities could represent the common complication diabetic peripheral neuropathy.  However, they could also be due to another etiology such as a spinal injury, peripheral vascular disease or multiple sclerosis.\nReferences\n:  For more information on\nexamples of rating decisions involving the complications of diabetes mellitus, see\nM21-1, Part V, Subpart iii, 11.4\n, and\navoidance of pyramiding, see\n38 CFR 4.14\n, and\nM21-1, Part V, Subpart ii, 3.D.2.b\n.\nV.iii.11.2.c\n.\nEffective Date for Diabetic Complications\nBecause diabetes mellitus is an endocrine disorder with potential multi-system effects, onset of diabetic complications represents medical progression or worsening of diabetes, and diabetic complications are contemplated in the evaluation criteria under\n38 CFR 4.119, DC 7913\n, a claim asserting new complications of SC diabetes is a claim for increase rather than a claim for secondary SC.\nTherefore, when assigning effective dates for new diabetic complications, consider effective date provisions applicable to increases, specifically\n38 CFR 3.400(o)\n, and\n38 CFR 3.157\nfor periods prior to March 24, 2015.\nReferences\n:  For more information on\neffective dates for\nSC diabetes mellitus, see\nM21-1, Part V, Subpart iii, 11.1.i\n, and\nincreased evaluations for diabetes mellitus, see\nM21-1, Part V, Subpart iii, 11.1.j\n, and\ndetermining the scope of, and examination requirements for, claims for diabetes, see\nM21-1, Part V, Subpart iii, 11.1.f\nand\ng\n.\nV.iii.11.2.d\n.\nCardiovascular Complications of Diabetes Mellitus\nDiabetic cardiovascular complications include, but are not limited to\nhypertension\natherosclerosis (used interchangeably with arteriosclerotic heart disease (coronary artery disease))\nperipheral arterial disease\nperipheral vascular disease\ncardiomyopathy\ncongestive heart failure, and\nstroke (macrovascular complication).\nReferences\n:  For more information on\ncardiovascular complications, see\nM21-1, Part V, Subpart iii, 5\n, and\n38 CFR 4.104\n, and\nmacrovascular complications to include stroke, see\n38 CFR 4.124(a)\n.\nV.iii.11.2.e\n.\nWhen Evidence Supports That Hypertension Is or Is Not a Complication of Diabetes Mellitus\nAnalyze the evidentiary record to determine if it contains evidence specifically addressing whether hypertension is or is not a complication of diabetes mellitus.\nIn the absence of record evidence specifically addressing the question of whether hypertension is related to diabetes mellitus\nconsider hypertension to be a complication of diabetes mellitus when onset of hypertension occurred after a diagnosis of diabetes mellitus with diabetic nephropathy (The onset of hypertension after diabetes mellitus without diabetic nephropathy is not sufficient.),\nand\ndo not consider hypertension to be a complication of diabetes mellitus when\nonset of hypertension was before diabetes mellitus (with or without diabetic nephropathy),\nand\nthere has been no change in the treatment of hypertension or increase in blood pressure readings.\nImportant\n:\nEvaluate the competency, credibility, and probative value of evidence in line with the principles in\nM21-1, Part V, Subpart ii, 1.A\n.\nThe analysis above should be used in determining whether or not to address unclaimed hypertension as a complication of diabetes mellitus and making a decision on the merits of the raised claim as detailed in\nM21-1, Part V, Subpart iii, 11.2.f\n.\nV.iii.11.2.f\n.\nAddressing Unclaimed Hypertension as a Complication of Diabetes Mellitus\nRaise and decide whether hypertension is a complication of diabetes mellitus in the absence of an explicit claim\nonly when\nthe evidence supports a grant.  Do not raise and deny the matter of entitlement to hypertension as a complication of diabetes mellitus when it is not explicitly claimed.\nDo not raise the issue simply because the record shows hypertension and diabetes mellitus (even if there is diabetic nephropathy).  This alone is not sufficient to support that hypertension is a complication of diabetes mellitus.\nImportant\n:  The policy stated in this block does not prohibit a determination of whether hypertension is a complication of diabetes mellitus\nwhen initial evaluation or reevaluation of diabetes mellitus is within the scope of the claim\n.  The scope and degree of severity of complications is part of any claim involving evaluation of diabetes mellitus.  However, the issue, unless explicitly claimed, should only be raised if SC may be awarded for hypertension as a complication of diabetes mellitus.\nV.iii.11.2.g\n.\nDevelopment on the Relationship Between Diabetes Mellitus and Hypertension\nThere are fact patterns where the evidence supports or does not support that hypertension is a complication of diabetes mellitus.\nIn the context of an explicit claim that hypertension is a complication of diabetes mellitus or in the context of evaluation of the extent of diabetes mellitus (to include whether there are complications of diabetes mellitus), a medical diagnosis or opinion may be necessary to determine whether hypertension is a complication of diabetes mellitus.\nWhen there is an explicit claim as discussed above, obtain a medical diagnosis or opinion to determine if hypertension is a complication of diabetes mellitus in the following fact patterns:\nmedical evidence shows\nhypertension was diagnosed\nbefore\ndiabetes mellitus or before diabetic nephropathy, but\nthere has been a subsequent change in the treatment of hypertension and/or an increase in blood pressure readings thereafter (particularly if this occurred after the onset of diabetic nephropathy), or\nmedical evidence shows no clear indication as to\nwhen hypertension was diagnosed, or\nwhether hypertension has worsened since the onset of diabetic nephropathy.\nImportant\n:  When there is not an explicit claim that hypertension is a complication of diabetes mellitus and when hypertension in an initial evaluation or reevaluation of diabetes mellitus is not within the scope of the claim,\ndo not\ndevelop for a diagnosis or opinion on whether hypertension is a complication of diabetes mellitus.\nV.iii.11.2.h\n.\nNeurological Complications of Diabetes Mellitus\nDiabetic neurological complications affecting the nervous system stem from a disturbance of metabolism or ischemia (inadequate blood supply) to the nerves.  One of the most common disabilities is peripheral neuropathy.  Complications affecting the peripheral nerves can extend from the brain and spinal cord to the muscles, skin, and internal organs.  The table below contains a description of symptoms that can be caused by a peripheral nerve disability.\nSymptoms of Peripheral Neuropathy\nDescription\nparesthesias\nnumbness, and\ntingling\nhyperesthesias\nincreased sensitivity to touch\nhypesthesia (or hypoesthesia)\ndecreased sensitivity to touch\nloss of sensation\nlack of feeling\npain\nburning\nlancinating, or\nlightning sensations\ndysesthesia\nunusual and unpleasant sensation after normal stimulation\nmuscle weakness\nlack of strength\nNote\n:  Findings are typically in a stocking-glove distribution.\nReference\n:  For more information on evaluating peripheral nerve disorders, see\nM21-1, Part V, Subpart iii, 12.A\n.\nV.iii.11.2.i\n.\nOphthalmological Complications of Diabetes Mellitus\nDiabetic ophthalmological complications are largely due to blood vessel damage caused by high blood sugars such as leakage (hemorrhage) and/or blood vessel blockage.  The table below contains a description of diabetic eye complications.\nDiabetic Eye Complications\nDescription\ndiabetic retinopathy\nimpairment or loss of vision due to damage affecting blood vessels of the retina\ncataract\nclouding or opaqueness of the lens of the eye\nglaucoma\nincreased fluid pressure in the eye, and\ncauses loss of visual fields due to optic nerve damage\nReference\n:  For more information on ophthalmological complications, see\nM21-1, Part V, Subpart iii, 2.A\n, and\n38 CFR 4.79\n.\nV.iii.11.2.j\n.\nGenitourinary Complications of Diabetes Mellitus\nDiabetic nephropathy is a common diabetic genitourinary complication of diabetes mellitus and may be rated based on criteria including\nrenal dysfunction, if renal function is affected\nvoiding dysfunction, if there is incontinence from autonomic nephropathy\nurinary tract infection, if there is chronic pyelonephritis, as appropriate\nkidney transplant\nhemodialysis, or\nnephrectomy.\nNote\n:  Erectile dysfunction (impotence/retrograde ejaculation) is another common complication of diabetes mellitus.\nReference\n:  For more information on genitourinary complications and potential entitlement to special monthly compensation (SMC), see\nM21-1, Part V, Subpart iii, 7\nM21-1, Part VIII, Subpart iv, 4.A\n38 CFR 4.115a\n, and\n38 CFR 4.115b\n.\nV.iii.11.2.k\n.\nMusculoskeletal Complications of Diabetes Mellitus\nDiabetic musculoskeletal complications affect the feet, ankles, bones, extremities, and overall gait.  The table below contains a description of diabetic musculoskeletal complications.\nDiabetic Musculoskeletal Complications\nDescription\nfoot complications\naffects muscles, joints, and bones\nfoot neuropathic ulcers\nresults from abnormal pressure and lack of sensitivity to pain\nleads to callus formation, osteomyelitis, and/or gangrene\nabnormalities of gait\nsensory ataxia to include loss of balance and poor muscle coordination due to loss of position sense\nCharcot joints (neuropathic osteoarthropathy)\ndegenerative changes\ninstability, and\npossible fragmentation of bones, particularly bones of the feet and ankles\namputations\nextremities, or\nparts of extremities\nReference\n:  For more information on musculoskeletal disabilities, see\nM21-1, Part V, Subpart iii, 1\n38 CFR 4.71a\n, and\n38 CFR 4.73\n.\nV.iii.11.2.l\n.\nImmune and Other Miscellaneous Complications of Diabetes Mellitus\nHyperglycemia causes the white blood cells of the immune system to function poorly.  In addition, all of the body's fluids have higher levels of sugar and nutrients, which make them more inviting for bacteria to grow and multiply.  This causes infections to be more serious and difficult to cure.  The table below contains a description of diabetic immune and other miscellaneous complications.\nDiabetic Immune and Other Miscellaneous Complications\nDescription\nReferences\nmalignant external otitis\na bacterial infection in older patients that causes\nsevere ear pain\nnecrosis of the external auditory canal, and\nfever, and may also cause\nparalysis of the facial nerve\nparalysis of other cranial nerves, and osteomyelitis of the base of the skull\nM21-1, Part V, Subpart iii, 2.B\n, and\n38 CFR 4.87\n.\nnasopharyngeal mucormycosis\na rare and serious fungal infection, which usually develops during or following an episode of diabetic ketoacidosis\nsudden onset with periorbital edema, pain, bloody nasal discharge, and increased lacrimation (tearing), and\nnasal mucosa and underlying tissues become black and necrotic\nM21-1, Part V, Subpart iii, 4.A\n, and\n38 CFR 4.97\n.\nemphysematous cholecystitis\nbegins as an attack of biliary colic, which rapidly progresses, and\nrecognized by x-rays that show gas in or around the gallbladder\nM21-1, Part V, Subpart iii, 6\n, and\n38 CFR 4.114\n.\nemphysematous pyelonephritis\nbegins as an attack of biliary colic, which rapidly progresses, and\nrecognized by x-rays that show gas in the kidney area\nM21-1, Part V, Subpart iii, 7\n38 CFR 4.115a\n, and\n38 CFR 4.115b\n.\nvaginal infection\nan inflammation of the vagina that creates discharge, odor, irritation, or itching\nM21-1, Part V, Subpart iii, 8.A\n, and\n38 CFR 4.116\n.\nurinary tract infection\ninfection in any part of the urinary system including kidneys, ureters, bladder, and urethra, or\na burning sensation, abdominal pain, and frequency in urination\nM21-1, Part V, Subpart iii, 7\n38 CFR 4.115a\n, and\n38 CFR 4.115b\n.\noral thrush\na yeast infection of the tongue, inner cheek, lip, or gums\nM21-1, Part V, Subpart iii, 6\n, and\n38 CFR 4.114\n.\nmoniliasis\nyeast infections affecting moist areas of the skin\nM21-1, Part V, Subpart iii, 10\n, and\n38 CFR 4.118\n.\ngastroparesis (paralysis of the stomach)\nsevere delayed gastric emptying (sometimes with dumping syndrome) due to vagus nerve involvement, and possible\nnausea, vomiting, early fullness in the stomach, bloating, abdominal pain, and weight loss\nM21-1, Part V, Subpart iii, 6\n, and\n38 CFR 4.114\nV.iii.11.2.m\n.\nSkin Complications of Diabetes Mellitus\nDiabetes mellitus may result in skin complications.  The table below contains a description of diabetic skin complications.\nDiabetic Skin Complications\nDescription\ncandida\nfungal infection, specifically a yeast infection in moist areas\ndermatophytes\na group of three types of fungus causing superficial infections of the skin, hair, and nails\nulcers\nsores on the skin to include disintegration of tissue\nnecrobiosis lipoidica diabeticorum\nplaque-like yellow to brown lesions over the anterior tibial surfaces of the legs that may ulcerate\ndiabetic dermopathy\n“shin spots” or small plaques with a raised border, also usually over the anterior tibial surfaces that may also ulcerate\nbullosis diabeticorum\nblisters spontaneously appearing on the hands or feet that heal in two to five weeks, sometimes with scarring and atrophy\natrophy of fatty tissue or skin thickening\nresulting from insulin injections\nReference\n:  For more information on skin disabilities, see\nM21-1, Part V, Subpart iii, 10\n, and\n38 CFR 4.118\n.\n3\n.\nThyroid Conditions\nIntroduction\nThis topic contains information about thyroid conditions, including\ndefinitions of hyper- and hypothyroidism\nevaluating thyroid disabilities after the initial diagnosis\nrating thyroid enlargement, nontoxic\ndefinition of myxedema\n, and\nchanges in the endocrine rating schedule\n.\nChange Date\nDecember 11, 2017\nV.iii.11.3.a\n.\nDefinitions:  Hyper- and Hypothyroidism\nHyperthyroidism (over-active thyroid)\nis a disorder where the thyroid gland synthesizes or creates excessive amounts of thyroid hormone.\nNote\n:  This condition may also be diagnosed as Graves’ disease.\nHypothyroidism\n(under-active thyroid)\nis a disorder where the thyroid gland does not produce enough thyroid hormone.\nV.iii.11.3.b\n.\nEvaluating Thyroid Disabilities After the Initial Diagnosis\nWhen a thyroid DC calls for an initial evaluation, the initial evaluation, by its very nature, is not considered static.  Most symptoms of these conditions are alleviated within the initial period of treatment.\nWhen the rating schedule requires the assignment of an evaluation for a specified period after the initial diagnosis, establish the initial evaluation for any applicable period for which the Veteran is eligible; and thereafter, evaluate based on residuals of the disease in the affected body system(s) as directed by the relevant DC.\nNotes\n:\nIn cases where the claim is being decided during the initial evaluation period, establish controls for a review exam at the end of that period to determine the appropriate evaluation.\nFor any complications shown on the review examination, follow the procedures in\nM21-1, Part IV, Subpart ii, 2.A.1.b\nfor awarding benefits for residuals of the primary SC disability.\nIf treatment for one form of thyroid dysfunction causes a new diagnosis of the other form of thyroid dysfunction, the Veteran is entitled to an initial evaluation for the newly diagnosed thyroid disease.\nReferences\n:  For more information on\nestablishing future exam control, see\nM21-1, Part IV, Subpart ii, 1.B\nstatic disabilities, see\nM21-1, Part IV, Subpart ii, 2.B.2.b\n, and\nM21-1, Part V, Subpart ii, 3.D.4\n, and\nevaluations of thyroid disabilities, see\n38 CFR 4.119\n.\nV.iii.11.3.c\n.\nRating Thyroid Enlargement, Nontoxic\nIn the context of thyroid function,\nnontoxic\nmeans that thyroid function is normal. Because thyroid function is normal, the disabling effects of nontoxic thyroid enlargement are generally either manifest as disfigurement or a result of pressure on adjacent organs (such as trachea, larynx, or esophagus). Evaluate this condition based on one or both of these effects, if present.\nReference\n: For more information on evaluating thyroid enlargement, nontoxic, see\n38 CFR 4.119, DC 7902\n.\nV.iii.11.3.d\n.\nDefinition: Myxedema\nMyxedema\n(coma or crisis) is a life-threatening form of hypothyroidism found predominantly in undiagnosed or undertreated individuals that requires inpatient hospitalization for stabilization.\nV.iii.11.3.e\n.\nChanges in the Endocrine Rating Schedule\nOn December 10, 2017, VA implemented changes in the rating criteria under\n38 CFR 4.119\n.  These changes should not be the basis of a reduction in a Veteran’s disability rating unless medical evidence establishes that the disability has actually improved.\nNote\n:  These changes in the rating criteria are not considered liberalizing.\nReferences\n:  For more information on\nthe effect of a rating schedule readjustment, see\n38 CFR 3.951\n, and\nM21-1, Part V, Subpart ii, 3.D.2.i\n, and\napplying new rating schedule criteria to increased rating claims, see\nM21-1, Part V, Subpart ii, 4.A.6.m\n.\n4\n.\nExamples of Rating Decisions Involving the Complications of Diabetes Mellitus\nIntroduction\nThis topic contains three examples of rating decisions involving the complications of diabetes mellitus, including\nexample 1 of a rating decision involving complications of diabetes mellitus\nexample 2 of a rating decision involving complications of diabetes mellitus\n, and\nexample 3 of a rating decision involving complications of diabetes mellitus\n.\nChange Date\nDecember 13, 2005\nV.iii.11.4.a\n.  Example 1: Rating Decision Involving Complications of Diabetes Mellitus\nSituation\n:  The Veteran has noncompensable complications of diabetes mellitus but does not have ketoacidosis or hypoglycemic reactions.\nResult\n:  Do not evaluate the diabetes mellitus at 60 percent simply because noncompensable complications are present.  Assign a 40-percent evaluation if there is a requirement of insulin, restricted diet, and regulation of activities.  Include the noncompensable complications under\n38 CFR 4.119, DC 7913\n.\nV.iii.11.4.b\n.  Example 2: Rating Decision Involving Complications of Diabetes Mellitus\nSituation\n:  The Veteran’s diabetes mellitus is controlled by insulin, restricted diet, and regulation of activities.  In addition, there is diabetic peripheral neuropathy compensable at 10 percent.\nResult\n:  Rate the diabetes mellitus at 40 percent and separately evaluate the compensable complication of diabetic peripheral neuropathy in accordance with the note under\n38 CFR 4.119, DC 7913\n.\nV.iii.11.4.c\n.  Example 3: Rating Decision Involving Complications of Diabetes Mellitus\nSituation\n:  The Veteran underwent a below-the-knee amputation due to complications of diabetes mellitus.  In addition\nhis diabetes mellitus requires\nmore than one daily injection of insulin\nrestricted diet, and\nregulation of activities\nhis episodes of ketoacidosis require weekly visits to the diabetic care provider, but\nthere is no progressive loss of weight and strength.\nResult\n:  Evaluate the diabetes mellitus at 100 percent and award SMC (k) for anatomical loss of a foot.  Since the below-the-knee amputation is secondary to diabetes mellitus, and is considered a compensable complication (in lieu of progressive loss of weight and strength), to warrant the 100-percent evaluation, it would be pyramiding to assign a separate 40-percent evaluation for the amputation.\nNote\n:  If compensable complications are not considered in reaching the 100- percent evaluation, they may be separately evaluated.\n<-- Previous Section\nNext Section -->\nTo Top",
  "content_html": "<div class=\"article-content\">\n<div compile-custom=\"article.content\" ng-aria=\"articleContent\"><p class=\"ng-scope\"></p><p class=\"ng-scope\" style=\"text-align: right\"><a articleid=\"554400000180515\" articlename=\"M21-1, Part V, Subpart iii, Chapter 10 - Skin Conditions\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180515/M21-1-Part-V-Subpart-iii-Chapter-10-Skin-Conditions\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\">&lt;-- Previous Section</span></span></a><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\">   <a articleid=\"554400000180519\" articlename=\"M21-1, Part V, Subpart iii, Chapter 12, Section A - Neurological Conditions and Convulsive Disorders\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180519/M21-1-Part-V-Subpart-iii-Chapter-12-Section-A-Neurological-Conditions-and-Convulsive-Disorders\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\">Next Section --&gt;</span></span></a></span></span></p><h2 class=\"ng-scope\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a id=\"top\" name=\"top\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">Overview</span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">       </span></span></span></span></h2><div class=\"ng-scope\" style=\"margin-left: 85pt\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">In This Chapter</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">This chapter contains the following topics:</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></span></span></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"border-spacing: 1px; border-collapse: revert;\" summary=\"Column 1 has the topic number and column 2 has the topic title.\"><thead><tr><th scope=\"col\" style=\"height: 23px; width: 86px; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Topic</strong></span></span></span></span></div></th><th scope=\"col\" style=\"height: 23px; width: 423px; padding: 1px;\"><div style=\"text-align: center\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Topic Name</strong></span></span></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 86px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">1 </span></span></span></span></div></td><td style=\"width: 423px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Diabetes Mellitus</span></span></a></span></span></div></td></tr><tr><td style=\"width: 86px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">2</span></span></span></span></div></td><td style=\"width: 423px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Complications of Diabetes Mellitus</span></span></a></span></span></div></td></tr><tr><td style=\"width: 86px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">3 </span></span></span></span></div></td><td style=\"width: 423px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Thyroid Conditions</span></span></a></span></span></div></td></tr><tr><td style=\"width: 86px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">4 </span></span></span></span></div></td><td style=\"width: 423px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#4\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Examples of Rating Decisions Involving the Complications of Diabetes Mellitus</span></span></a></span></span></div></td></tr></tbody></table><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/><br/><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></span></span></div><h2 class=\"ng-scope\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">1<a id=\"1\" name=\"1\">.</a>  Diabetes Mellitus</span></span></span></span></h2><p class=\"ng-scope\"></p><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Introduction</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This topic contains information about diabetes mellitus, including</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1a\" target=\"_self\">definition of diabetes mellitus</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1b\" target=\"_self\">symptoms of diabetes mellitus</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1c\" target=\"_self\">evaluating diabetes mellitus</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1d\" target=\"_self\">successive criteria requirement for the next higher disability evaluation</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1e\" target=\"_self\">information on regulation of activities</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1f\" target=\"_self\">scope of diabetes mellitus claims</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1g\" target=\"_self\">requesting examinations for diabetes mellitus or diabetic complications </a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1h\" target=\"_self\">failure to report in claims for increase in diabetes mellitus,</a> and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">effective dates for </span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1i\" target=\"_self\">service connection (SC) of diabetes mellitus</a>, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1j\" target=\"_self\">claims for increase of diabetes mellitus</a>.</span></span></span></span></div></li></ul></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Change Date</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\">June 6, 2024</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.1.a<a id=\"1a\" name=\"1a\">.</a>  Definition: Diabetes Mellitus</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Diabetes mellitus </em></strong>is a metabolic disorder in which the body is unable to use glucose (a type of sugar obtained from food) effectively.  Hyperglycemia, an abnormally high level of blood sugar, results.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Diabetes mellitus is not seriously disabling if, on a diet sufficient to maintain the weight and strength of the claimant, the</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">blood glucose can be kept within normal limits, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">urine is absent glucose.</span></span></span></span></div></li></ul><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">As diabetes mellitus progresses</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">it becomes more difficult to control, even with insulin</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">complications develop which increase the degree of disability, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">increasing limitation of activity due to unstable blood sugar levels limits employability.</span></span></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.1.b<a name=\"1b\">.</a>  Symptoms of Diabetes Mellitus</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The cardinal symptoms of uncontrolled diabetes mellitus are</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">polyuria (excessive urination)</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">polydipsia (excessive thirst)</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">polyphagia (excessive hunger)</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">weakness, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">loss of weight.</span></span></span></span></div></li></ul><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The presence of sugar in the urine is characteristic of, but not essential to, a diagnosis of diabetes mellitus.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Notes</em></strong>: </span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">A diagnosis of diabetes mellitus cannot be made from glycosuria alone, as this may result from</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">a low renal threshold for sugar, or</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">excessive ingestion of sugar. </span></span></span></span></div></li></ul></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Persistent hyperglycemia, a blood sugar of 170 milligrams (mg) per 100 cubic centimeters (ccs) blood after 12-hour fast, and glycosuria may be related to</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">hyperthyroidism</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">dyspituitarism</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">pregnancy</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">apoplexy</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">cerebral trauma, or</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">severe infections.</span></span></span></span></div></li></ul></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.1.c<a id=\"1c\" name=\"1c\">.</a>  Evaluating Diabetes Mellitus</span></span></span></span></h3><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Evaluations of diabetes mellitus are assigned under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=ff0446622e8f862b4088917492918417&amp;node=se38.1.4_1119&amp;rgn=div8\" target=\"_blank\">38 CFR 4.119, diagnostic code (DC) 7913</a>.  The diagnostic criteria take into account</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the means necessary to control diabetes, specifically </span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">restricted diet</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">oral hypoglycemic agent</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">one or more daily injection of insulin, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">regulation of activities</span></span></span></span></div></li></ul></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">frequency of specific types of care for episodes of ketoacidosis or hypoglycemic reactions </span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">hospitalizations, or</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">visits to a diabetic care provider</span></span></span></span></div></li></ul></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">progressive loss of weight and strength, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">diabetic complications.  </span></span></span></span></div></li></ul><div><span style=\"font-size:14px;\"><span style=\"font-family:Arial,Helvetica,sans-serif;\"><em><strong>Note</strong></em>:  To treat diabetes mellitus, medical providers may prescribe non-insulin injectable medications, such as Ozempic, Victoza, Trulicity, or other generic versions.  These medications are distinctly different from injectable insulin.  Like oral hypoglycemic agents, non-insulin injectable medications help lower blood glucose levels.  For rating purposes, evaluate a prescription for a non-insulin injectable medication in the same manner as a prescription for an oral hypoglycemic agent.  Do <em><strong>not</strong></em> consider a non-insulin injectable medication as equivalent to treatment with insulin. </span></span></div><div></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">evaluating complications of diabetes mellitus, see <a href=\"#2b\" target=\"_self\">M21-1, Part V, Subpart iii, 11.2.b</a>, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">scope of diabetes mellitus claims, see <a href=\"#1f\" target=\"_self\">M21-1, Part V, Subpart iii, 11.1.f</a>.</span></span></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.1.d<a id=\"1d\" name=\"1d\">.</a> Successive Criteria Requirement for the Next Higher Disability Evaluation</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When determining the appropriate disability evaluation to assign for diabetes mellitus, note that the criteria are successive.  This means the Veteran can <strong><em>only</em></strong> be rated at the next higher disability evaluation when all criteria at the lower disability evaluation are met plus element(s) specific to the higher evaluation are satisfied.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on </span></span></span></span></div><ul><li><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">diabetes mellitus, see</span></span> </span></span><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=ff0446622e8f862b4088917492918417&amp;node=se38.1.4_1119&amp;rgn=div8\" target=\"_blank\">38 CFR 4.119, DC 7913</a>, and </span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em><a articleid=\"554400000014801\" articlename=\"Camacho v. Nicholson, Jul 6, 2007, 21 Vet.App. 360\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014801/Camacho-v-Nicholson-Jul-6-2007-21-VetApp-360\">Camacho v. Nicholson</a></em>, 21 Vet.App. 360 (2007), and</span></span></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">relationships within evaluation criteria, see <a articleid=\"554400000180489\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section D - Evaluating Disabilities\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180489/M21-1-Part-V-Subpart-ii-Chapter-3-Section-D-Evaluating-Disabilities\">M21-1, Part V, Subpart ii, 3.D.2.a</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.1.e<a id=\"1e\" name=\"1e\">.</a> Information on Regulation of Activities</span></span></span></span></h3><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The term <strong><em>regulation of activities</em></strong> is defined parenthetically in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=ff0446622e8f862b4088917492918417&amp;node=se38.1.4_1119&amp;rgn=div8\" target=\"_blank\">38 CFR 4.119, DC 7913</a> to mean the requirement of “avoidance of strenuous occupational and recreational activities.”  In turn, this must be understood as meaning that the avoidance is <em>required</em> to help control blood sugar.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Voluntary avoidance of strenuous activity by the Veteran, undertaken with the intention of avoiding hypoglycemic episodes, does <em>not</em> meet the regulatory criteria.  Evidence must document that the avoidance of strenuous activities is required/prescribed as part of medical management of the individual’s diabetes.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Prescribed or voluntary exercise also does not satisfy the regulation-of-activities criterion.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Notes</em></strong>: </span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Which specific activities are medically contraindicated as strenuous (what medical restrictions have been prescribed) is a factual medical question. </span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The <em>Diabetes Mellitus</em> <em>Disability Benefits Questionnaire</em> (DBQ) requires that the examiner address whether avoidance of strenuous occupational and recreational activities to avoid hypoglycemic episodes is required as part of medical management of diabetes mellitus, and if so, to provide examples. </span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The conclusion that “regulation of activities” is demonstrated is an adjudicative determination. </span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">It is the Department of Veteran’s Affairs (VA’s) policy to concede that an individual’s diabetes mellitus requires insulin, restricted diet, and regulation of activities when the diabetes has caused episodes of ketoacidosis that have resulted in hospitalization.  </span></span></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.1.f<a id=\"1f\" name=\"1f\">.</a>   Scope of Diabetes Mellitus Claims</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">As discussed in <a articleid=\"554400000180486\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section A - Determining the Issues\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180486/M21-1-Part-V-Subpart-ii-Chapter-3-Section-A-Determining-the-Issues\">M21-1, Part V, Subpart ii, 3.A</a>, determining what issues are within scope of a claim is a case-by-case determination based on a sympathetic reading of the evidence.</span></span></span></span></div><div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When reviewing claims for diabetes mellitus, including diabetic complications, consider whether the evidence establishes entitlement to </span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">an increased evaluation for the</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">diabetes mellitus, and/or</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">service-connected (SC) complication(s), and/or</span></span></span></span></div></li></ul></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">service connection (SC) for expressly claimed or newly discovered, unclaimed complications.</span></span></span></span></div></li></ul><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em><strong>Notes</strong></em>:  </span></span></span></span></div></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">As complications of diabetes mellitus are part of the evaluation criteria for the disease, entitlement to any additional benefits based on complications would be considered within scope of the claim.  </span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Follow the guidance in <a articleid=\"554400000180486\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section A - Determining the Issues\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180486/M21-1-Part-V-Subpart-ii-Chapter-3-Section-A-Determining-the-Issues\">M21-1, Part V, Subpart ii, 3.A.2.c</a> for handling complications of an expressly claimed issue, including when to obtain adequate medical evidence, such as an examination.</span></span></div></li></ul><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">claim requirements and scope of claim, see <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=578da4e1b9e5912d873a7d6fcd7b8ae3&amp;mc=true&amp;node=se38.1.3_1155&amp;rgn=div8\" target=\"_blank\">38 CFR 3.155</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">clarifying issues and claims, see <a articleid=\"554400000033257\" articlename=\"M21-1, Part III, Subpart i, Chapter 2, Section D - Evidence Requested From the Claimant\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000033257/M21-1-Part-III-Subpart-i-Chapter-2-Section-D-Evidence-Requested-From-the-Claimant\">M21-1, Part III, Subpart i, 2.D.1.c</a>, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">addressing unclaimed hypertension as a complication of diabetes mellitus, see <a href=\"#2f\" target=\"_self\">M21-1, Part V, Subpart iii, 11.2.f</a>. </span></span></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.1.g<a id=\"1g\" name=\"1g\">.</a> Requesting Examinations for Diabetes Mellitus or Diabetic Complications</span></span></span></span></h3><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; text-align: left; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Refer to the table below for general guidance on determining which examinations to request in claims for diabetes mellitus or diabetic complications. </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">   </span></span></span></span><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is an If-Then table.  Column 1 provides the criteria and column 2 provides the guidance on determining which examination to request.\" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 192px; padding: 1px;\"><p style=\"text-align: left\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>If the claim wording is interpreted as requesting compensation for ...</strong></span></span></span></span></p></th><th scope=\"col\" style=\"width: 318px; padding: 1px;\"><p style=\"text-align: left\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Then request ...</strong></span></span></span></span></p></th></tr></thead><tbody><tr><td style=\"width: 192px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">diabetes mellitus (initial SC or an increased evaluation) with or without complications specified</span></span></span></span></div></td><td style=\"width: 318px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the <em>Diabetes Mellitus Disability Benefits Questionnaire</em>, when necessary to decide the claim.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Important</em></strong>:</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If the Veteran explicitly claims a diabetic complication (new or increased evaluation), or is already SC for a complication(s), include a comment in the examination request to alert the examiner.</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The <em>Diabetes Mellitus Disability Benefits Questionnaire</em> must address all diabetic complications present, to include completion of additional DBQs as appropriate.</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If the examiner fails to address all diabetic complications and complete all necessary DBQs, the examination must be returned as insufficient.</span></span></span></span></div></li></ul></td></tr><tr><td style=\"width: 192px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">a specified diabetic complication(s) (new or an increased evaluation)</span></span></span></span></div></td><td style=\"width: 318px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the specific DBQ(s) associated with the claimed complication(s), when necessary to decide the claim.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  Do <em><strong>not</strong></em> request the <em>Diabetes Mellitus Disability Benefits Questionnaire</em>.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Important</em></strong>:  Worsening of a diabetic complication could indicate a broader worsening of the diabetes generally.  When worsening in the diabetic process is shown, follow procedures for deciding all issues within scope of the claim as outlined in</span></span> </span></span><ul><li><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#1f\" target=\"_self\">M21-1, Part V, Subpart iii, 11.1.f</a>, and</span></span> </span></span></li><li><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000180486\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section A - Determining the Issues\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180486/M21-1-Part-V-Subpart-ii-Chapter-3-Section-A-Determining-the-Issues\">M21-1, Part V, Subpart ii, 3.A.2.c</a>.</span></span> </span></span></li></ul></div></td></tr></tbody></table></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on </span></span></span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">when an examination is necessary to decide a claim, see <a articleid=\"554400000180494\" articlename=\"M21-1, Part IV, Subpart i, Chapter 1, Section A - Duty to Assist With Providing a Medical Examination or Opinion\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180494/M21-1-Part-IV-Subpart-i-Chapter-1-Section-A-Duty-to-Assist-With-Providing-a-Medical-Examination-or-Opinion\">M21-1, Part IV, Subpart i, 1.A</a> and <a articleid=\"554400000180495\" articlename=\"M21-1, Part IV, Subpart i, Chapter 1, Section B - Evidentiary Standards for Finding an Examination or Opinion Necessary\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180495/M21-1-Part-IV-Subpart-i-Chapter-1-Section-B-Evidentiary-Standards-for-Finding-an-Examination-or-Opinion-Necessary\">B</a>, and</span></span></li><li><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">developing for a relationship between diabetes mellitus and hypertension, see <a href=\"#2g\" target=\"_self\">M21-1, Part V, Subpart iii, 11.2.g</a>.</span></span> </span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.1.h<a id=\"1h\" name=\"1h\">.</a> Failure to Report in Claims for Increase in Diabetes Mellitus</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">See the table below for guidance on the correct rating action to take when a claimant fails to report for a necessary VA examination in connection with a claim for increase for diabetes mellitus.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"border-spacing: 1px; border-collapse: revert;\" summary=\"This is an if-then table.  Column 1 provides the criteria and column 2 provides guidance on the correct rating action to take when a claimant fails to report for a necessary VA examination in connection with a claim for increase for diabetes mellitus.\"><thead><tr><th scope=\"col\" style=\"width: 194px; padding: 1px;\"><p style=\"text-align: left\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>If the claim ...</strong></span></span></span></span></p></th><th scope=\"col\" style=\"width: 316px; padding: 1px;\"><p style=\"text-align: left\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Then ...</strong></span></span></span></span></p></th></tr></thead><tbody><tr><td style=\"width: 194px; vertical-align: top; padding: 1px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">is limited to an increase in one or more separately evaluated diabetic complications</span></span></span></span></p></td><td style=\"width: 316px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">deny an increase for the claimed complication(s) based on failure to report for the examination without good cause.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Exception</em></strong>:  If the other evidence of record is sufficient to address the evaluation criteria for the claimed complication(s), issue a grant or denial as supported by that evidence.</span></span></span></span></div></td></tr><tr><td style=\"width: 194px; vertical-align: top; padding: 1px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">expressly refers to a reevaluation or increase for diabetes mellitus, whether or not it mentions complications</span></span></span></span></p><p style=\"margin-left: -1.45pt\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 316px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">deny</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">an increase in the evaluation for the diabetic process, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">any expressly claimed diabetic complications.</span></span></span></span></div></li></ul><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Exception</em></strong>:  Evaluate the evidence of record in accordance with <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=9c14819d0bc041f9805b8b177bac2dee&amp;mc=true&amp;node=se38.1.3_1326&amp;rgn=div8\" target=\"_blank\">38 CFR 3.326</a> to determine if it is otherwise adequate for rating purposes without a VA examination.  If it is, make a decision based on that evidence.  </span></span></span></span></div></td></tr></tbody></table><div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on failure to report for examinations in connection with a claim for an increased evaluation, see </span></span></span></span><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=7941a3130baebed52275ce222d379779&amp;mc=true&amp;node=se38.1.3_1655&amp;rgn=div8\" target=\"_blank\">38 CFR 3.655(b)</a></span></span></span></span><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">.</span></span></span></span></div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.1.i<a id=\"1i\" name=\"1i\">.</a> Effective Dates for SC of Diabetes Mellitus</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">For SC of diabetes, the effective date is generally the later of the date of claim or date entitlement arose.  This includes the effective date for</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">any evaluation of the diabetic process, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">any separate evaluation of diabetic complications.</span></span></span></span></div></li></ul><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Important</em></strong>:  Consider entitlement to an earlier effective date, when applicable, under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=e2f73f1caf49a1d2a2c8556e7cedb991&amp;mc=true&amp;node=se38.1.3_1114&amp;rgn=div8\" target=\"_blank\">38 CFR 3.114</a> and the <em>Nehmer</em> stipulation.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assignment of effective dates for SC, see <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=66ebdb01f4461c9b7dd53fbd1eb989cb&amp;mc=true&amp;node=se38.1.3_1400&amp;rgn=div8\" target=\"_blank\">38 CFR 3.400</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">effective dates for diabetic complications, see <a href=\"#2c\" target=\"_self\">M21-1, Part V, Subpart iii, 11.2.c</a>, and</span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the <em>Nehmer</em> stipulation, see <a articleid=\"554400000177424\" articlename=\"M21-1, Part VIII, Subpart i, Chapter 2, Section A - Developing Claims Under the Nehmer Stipulation\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177424/M21-1-Part-VIII-Subpart-i-Chapter-2-Section-A-Developing-Claims-Under-the-Nehmer-Stipulation\">M21-1, Part VIII, Subpart i, 2</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.1.j<a id=\"1j\" name=\"1j\">.</a> Effective Dates for Claims for Increase of Diabetes Mellitus</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=66ebdb01f4461c9b7dd53fbd1eb989cb&amp;mc=true&amp;node=se38.1.3_1400&amp;rgn=div8\" target=\"_blank\">38 CFR 3.400(o)</a>, assign increased evaluations of diabetes mellitus from</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the date an ascertainable increase in the disability occurred if a complete claim or intent to file a claim is received within one year from such date, otherwise</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">date of receipt of claim.</span></span></span></span></div></li></ul><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> <strong><em>Notes</em></strong>: </span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Prior to March 24, 2015, <a href=\"http://www.gpo.gov/fdsys/pkg/CFR-2014-title38-vol1/pdf/CFR-2014-title38-vol1-sec3-157.pdf\" target=\"_blank\">38 CFR 3.157</a> was in effect.  Under that regulation, certain records showing treatment could be considered claims for increase.</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Effective March 24, 2015, claims must be filed on standard forms and records are no longer treated as claims for increase.</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Development of new diabetic complications is evidence of an ascertainable increase in the diabetic process.</span></span></span></span></div></li></ul><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">effective dates for diabetic complications, see <a href=\"#2c\" target=\"_self\">M21-1, Part V, Subpart iii, 11.2.c</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">historical treatment of treatment records as claims, see <a href=\"http://www.gpo.gov/fdsys/pkg/CFR-2014-title38-vol1/pdf/CFR-2014-title38-vol1-sec3-157.pdf\" target=\"_blank\">38 CFR 3.157</a></span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">informal claims received prior to March 24, 2015, see <a articleid=\"554400000174880\" articlename=\"M21-1, Part II, Subpart iii, Chapter 2, Section H - Historical Guidance on Formal Applications and Informal Claims Received Prior to March 24, 2015\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000174880/M21-1-Part-II-Subpart-iii-Chapter-2-Section-H-Historical-Guidance-on-Formal-Applications-and-Informal-Claims-Received-Prior-to-March-24-2015\">M21-1, Part II, Subpart iii, 2.H</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">intent to file, see <a articleid=\"554400000174873\" articlename=\"M21-1, Part II, Subpart iii, Chapter 2, Section A - Intent to File (ITF)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000174873/M21-1-Part-II-Subpart-iii-Chapter-2-Section-A-Intent-to-File-ITF\">M21-1, Part II, Subpart iii, 2.A</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">requests for application, see <a articleid=\"554400000174879\" articlename=\"M21-1, Part II, Subpart iii, Chapter 2, Section G - Requests for Application and Claims Solicitation\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000174879/M21-1-Part-II-Subpart-iii-Chapter-2-Section-G-Requests-for-Application-and-Claims-Solicitation\">M21-1, Part II, Subpart iii, 2.G</a>, and</span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">how to file a claim, see <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=46329ddeee04ec59e533ad235a9cf52e&amp;mc=true&amp;node=se38.1.3_1155&amp;rgn=div8\" target=\"_blank\">38 CFR 3.155</a>.</span></span></span></span></div></li></ul></td></tr></tbody></table><hr class=\"ng-scope\"/><p class=\"ng-scope\"></p><h2 class=\"ng-scope\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 16px\"><strong><span style=\"font-family: arial , helvetica , sans-serif\">2<a id=\"2\" name=\"2\">.</a>  Complications of Diabetes Mellitus</span></strong></span></span></span></h2><p class=\"ng-scope\"></p><p class=\"ng-scope\"><br/><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></p><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Introduction</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This topic contains information about complications of diabetes mellitus, including</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2a\" target=\"_self\">common complications of diabetes mellitus</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2b\" target=\"_self\">evaluating complications of diabetes mellitus</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2c\" target=\"_self\">effective date for diabetic complications</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2d\" target=\"_self\">cardiovascular complications of diabetes mellitus</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2e\" target=\"_self\">when evidence supports that hypertension is or is not a complication of diabetes mellitus</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2f\" target=\"_self\">addressing unclaimed hypertension as a complication of diabetes mellitus</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2g\" target=\"_self\">development on the relationship between diabetes mellitus and hypertension</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2h\" target=\"_self\">neurological complications of diabetes mellitus</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2i\" target=\"_self\">ophthalmological complications of diabetes mellitus</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2j\" target=\"_self\">genitourinary complications of diabetes mellitus</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2k\" target=\"_self\">musculoskeletal complications of diabetes mellitus</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2l\" target=\"_self\">immune and other miscellaneous complications of diabetes mellitus</a>, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2m\" target=\"_self\">skin complications of diabetes mellitus</a>.</span></span></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Change Date</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">November 29, 2016</span></span></span></span></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.2.a<a id=\"2a\" name=\"2a\">.</a> Common Complications of Diabetes Mellitus</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">As noted in <a href=\"#1a\" target=\"_self\">M21-1, Part V, Subpart iii, 11.1.a</a>, complications are disabilities of various body systems, including but not limited to the following, caused by progression of diabetes:</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">cardiovascular</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">neurological</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">ophthalmological</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">genitourinary</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">gynecological</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">musculoskeletal</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">immune, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">skin.</span></span></span></span></div></li></ul><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Notes</em></strong>:  Once diabetic complications begin, multiple complications are usually considered or involved.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on scope of claim and examination requirements in claims for diabetes mellitus, see <a href=\"#1f\" target=\"_self\">M21-1, Part V, Subpart iii, 11.1.f</a> and <a href=\"#1g\" target=\"_self\">g</a>.</span></span></span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" spellcheck=\"false\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.2.b<a id=\"2b\" name=\"2b\">.</a> Evaluating Complications of Diabetes Mellitus</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Per <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=ff0446622e8f862b4088917492918417&amp;node=se38.1.4_1119&amp;rgn=div8\" target=\"_blank\">38 CFR 4.119, DC 7913</a>, evaluate compensable complications of diabetes mellitus separately unless they are a part of the criteria used to support a 100-percent evaluation. </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Noncompensable complications are considered part of the diabetic process under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=ff0446622e8f862b4088917492918417&amp;node=se38.1.4_1119&amp;rgn=div8\" target=\"_blank\">38 CFR 4.119, DC 7913</a>.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Before conceding that a particular disability is a complication of diabetes, ensure that there is medical evidence of record supporting that determination.  In some cases, a particular disability of a body part of system could be a diabetic complication or it could be due to another cause.  For example, neurological symptoms in the lower extremities could represent the common complication diabetic peripheral neuropathy.  However, they could also be due to another etiology such as a spinal injury, peripheral vascular disease or multiple sclerosis.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">examples of rating decisions involving the complications of diabetes mellitus, see<a href=\"#4\" target=\"_self\"> M21-1, Part V, Subpart iii, 11.4</a></span></span></span></span><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">avoidance of pyramiding, see </span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=2&amp;SID=f4fc5b9f32005906d099c84f3082247e&amp;ty=HTML&amp;h=L&amp;r=SECTION&amp;n=se38.1.4_114\" target=\"_blank\">38 CFR 4.14</a>, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000180489\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section D - Evaluating Disabilities\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180489/M21-1-Part-V-Subpart-ii-Chapter-3-Section-D-Evaluating-Disabilities\">M21-1, Part V, Subpart ii, 3.D.2.b</a>.</span></span></span></span></div></li></ul></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.2.c<a id=\"2c\" name=\"2c\">.</a> Effective Date for Diabetic Complications</span></span></span></span></h3><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Because diabetes mellitus is an endocrine disorder with potential multi-system effects, onset of diabetic complications represents medical progression or worsening of diabetes, and diabetic complications are contemplated in the evaluation criteria under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=ff0446622e8f862b4088917492918417&amp;node=se38.1.4_1119&amp;rgn=div8\" target=\"_blank\">38 CFR 4.119, DC 7913</a>, a claim asserting new complications of SC diabetes is a claim for increase rather than a claim for secondary SC. </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Therefore, when assigning effective dates for new diabetic complications, consider effective date provisions applicable to increases, specifically</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=66ebdb01f4461c9b7dd53fbd1eb989cb&amp;mc=true&amp;node=se38.1.3_1400&amp;rgn=div8\" target=\"_blank\">38 CFR 3.400(o)</a>, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.gpo.gov/fdsys/pkg/CFR-2014-title38-vol1/pdf/CFR-2014-title38-vol1-sec3-157.pdf\" target=\"_blank\">38 CFR 3.157</a> for periods prior to March 24, 2015. </span></span></span></span></div></li></ul><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on </span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">effective dates for </span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">SC diabetes mellitus, see <a href=\"#1i\" target=\"_self\">M21-1, Part V, Subpart iii, 11.1.i</a>, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">increased evaluations for diabetes mellitus, see <a href=\"#1j\" target=\"_self\">M21-1, Part V, Subpart iii, 11.1.j</a>, and</span></span></span></span></div></li></ul></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">determining the scope of, and examination requirements for, claims for diabetes, see <a href=\"#1f\" target=\"_self\">M21-1, Part V, Subpart iii, 11.1.f</a> and <a href=\"#1g\" target=\"_self\">g</a>. </span></span></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.2.d<a id=\"2d\" name=\"2d\">.</a> Cardiovascular Complications of Diabetes Mellitus</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Diabetic cardiovascular complications include, but are not limited to</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">hypertension</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">atherosclerosis (used interchangeably with arteriosclerotic heart disease (coronary artery disease))</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">peripheral arterial disease</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">peripheral vascular disease</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">cardiomyopathy</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">congestive heart failure, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">stroke (macrovascular complication).</span></span></span></span></div></li></ul><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">cardiovascular complications, see</span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000014520\" articlename=\"M21-1, Part V, Subpart iii, Chapter 5 - Cardiovascular System Conditions\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014520/M21-1-Part-V-Subpart-iii-Chapter-5-Cardiovascular-System-Conditions\">M21-1, Part V, Subpart iii, 5</a>, and</span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=1&amp;SID=f4fc5b9f32005906d099c84f3082247e&amp;ty=HTML&amp;h=L&amp;r=SECTION&amp;n=se38.1.4_1104\" target=\"_blank\">38 CFR 4.104</a>, and</span></span></span></span></div></li></ul></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">macrovascular complications to include stroke, see <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=aee3a09b2de7f04436d9b078d17d0779&amp;node=se38.1.4_1124a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.124(a)</a>.</span></span></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.2.e<a id=\"2e\" name=\"2e\">.</a> When Evidence Supports That Hypertension Is or Is Not a Complication of Diabetes Mellitus</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Analyze the evidentiary record to determine if it contains evidence specifically addressing whether hypertension is or is not a complication of diabetes mellitus.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">In the absence of record evidence specifically addressing the question of whether hypertension is related to diabetes mellitus</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">consider hypertension to be a complication of diabetes mellitus when onset of hypertension occurred after a diagnosis of diabetes mellitus with diabetic nephropathy (The onset of hypertension after diabetes mellitus without diabetic nephropathy is not sufficient.), <strong><em>and </em></strong></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">do not consider hypertension to be a complication of diabetes mellitus when</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">onset of hypertension was before diabetes mellitus (with or without diabetic nephropathy), <strong><em>and</em></strong></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">there has been no change in the treatment of hypertension or increase in blood pressure readings.</span></span></span></span></div></li></ul></li></ul><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Important</em></strong>:  </span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Evaluate the competency, credibility, and probative value of evidence in line with the principles in <a articleid=\"554400000014383\" articlename=\"M21-1, Part V, Subpart ii, Chapter 1, Section A - Principles of Reviewing and Weighing Evidence\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014383/M21-1-Part-V-Subpart-ii-Chapter-1-Section-A-Principles-of-Reviewing-and-Weighing-Evidence\">M21-1, Part V, Subpart ii, 1.A</a>.</span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">The analysis above should be used in determining whether or not to address unclaimed hypertension as a complication of diabetes mellitus and making a decision on the merits of the raised claim as detailed in <a href=\"#2f\" target=\"_self\">M21-1, Part V, Subpart iii, 11.2.f</a>.</span></span></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.2.f<a id=\"2f\" name=\"2f\">.</a>  Addressing Unclaimed Hypertension as a Complication of Diabetes Mellitus</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Raise and decide whether hypertension is a complication of diabetes mellitus in the absence of an explicit claim <strong><em>only when</em></strong> the evidence supports a grant.  Do not raise and deny the matter of entitlement to hypertension as a complication of diabetes mellitus when it is not explicitly claimed. </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Do not raise the issue simply because the record shows hypertension and diabetes mellitus (even if there is diabetic nephropathy).  This alone is not sufficient to support that hypertension is a complication of diabetes mellitus.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Important</em></strong>:  The policy stated in this block does not prohibit a determination of whether hypertension is a complication of diabetes mellitus <strong><em>when initial evaluation or reevaluation of diabetes mellitus is within the scope of the claim</em></strong>.  The scope and degree of severity of complications is part of any claim involving evaluation of diabetes mellitus.  However, the issue, unless explicitly claimed, should only be raised if SC may be awarded for hypertension as a complication of diabetes mellitus.</span></span></span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.2.g<a id=\"2g\" name=\"2g\">.</a> Development on the Relationship Between Diabetes Mellitus and Hypertension</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">There are fact patterns where the evidence supports or does not support that hypertension is a complication of diabetes mellitus.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">In the context of an explicit claim that hypertension is a complication of diabetes mellitus or in the context of evaluation of the extent of diabetes mellitus (to include whether there are complications of diabetes mellitus), a medical diagnosis or opinion may be necessary to determine whether hypertension is a complication of diabetes mellitus. </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When there is an explicit claim as discussed above, obtain a medical diagnosis or opinion to determine if hypertension is a complication of diabetes mellitus in the following fact patterns:</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">medical evidence shows</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">hypertension was diagnosed <em>before</em> diabetes mellitus or before diabetic nephropathy, but</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">there has been a subsequent change in the treatment of hypertension and/or an increase in blood pressure readings thereafter (particularly if this occurred after the onset of diabetic nephropathy), or</span></span></span></span></div></li></ul></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">medical evidence shows no clear indication as to</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">when hypertension was diagnosed, or</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">whether hypertension has worsened since the onset of diabetic nephropathy.</span></span></span></span></div></li></ul></li></ul><div><span style=\"font-family:Arial,Helvetica,sans-serif;\"><span style=\"font-size: 11px\"><span style=\"font-size: 14px\"><strong><em>Important</em></strong>:  When there is not an explicit claim that hypertension is a complication of diabetes mellitus and when hypertension in an initial evaluation or reevaluation of diabetes mellitus is not within the scope of the claim, <strong><em>do not </em></strong>develop for a diagnosis or opinion on whether hypertension is a complication of diabetes mellitus.</span></span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.2.h<a id=\"2h\" name=\"2h\">.</a> Neurological Complications of Diabetes Mellitus</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Diabetic neurological complications affecting the nervous system stem from a disturbance of metabolism or ischemia (inadequate blood supply) to the nerves.  One of the most common disabilities is peripheral neuropathy.  Complications affecting the peripheral nerves can extend from the brain and spinal cord to the muscles, skin, and internal organs.  The table below contains a description of symptoms that can be caused by a peripheral nerve disability.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"Column 1 provides the symptoms of peripheral neuropathy and comlumn 2 provides a description.\" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 258px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Symptoms of Peripheral Neuropathy</strong></span></span></span></span></div></th><th scope=\"col\" style=\"width: 252px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Description</strong></span></span></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 258px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">paresthesias</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">numbness, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">tingling</span></span></span></span></div></li></ul></td></tr><tr><td style=\"width: 258px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">hyperesthesias</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">increased sensitivity to touch</span></span></span></span></div></td></tr><tr><td style=\"width: 258px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">hypesthesia (or hypoesthesia)</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">decreased sensitivity to touch</span></span></span></span></div></td></tr><tr><td style=\"width: 258px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">loss of sensation</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">lack of feeling</span></span></span></span></div></td></tr><tr><td style=\"width: 258px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">pain</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">burning</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">lancinating, or</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">lightning sensations</span></span></span></span></div></li></ul></td></tr><tr><td style=\"width: 258px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">dysesthesia</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">unusual and unpleasant sensation after normal stimulation</span></span></span></span></div></td></tr><tr><td style=\"width: 258px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">muscle weakness</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">lack of strength</span></span></span></span></div></td></tr></tbody></table><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></span></span></div><div><span style=\"font-family:Arial,Helvetica,sans-serif;\"><span style=\"font-size: 11px\"><span style=\"font-size: 14px\"><strong><em>Note</em></strong>:  Findings are typically in a stocking-glove distribution.</span></span></span></div><div><span style=\"font-family:Arial,Helvetica,sans-serif;\"><span style=\"font-size: 11px\"><span style=\"font-size: 14px\">  </span></span></span></div><div><span style=\"font-family:Arial,Helvetica,sans-serif;\"><span style=\"font-size: 11px\"><span style=\"font-size: 14px\"><strong><em>Reference</em></strong>:  For more information on evaluating peripheral nerve disorders, see</span></span></span></div><div><span style=\"font-family:Arial,Helvetica,sans-serif;\"><span style=\"font-size: 11px\"><span style=\"font-size: 14px\"><a articleid=\"554400000180519\" articlename=\"M21-1, Part V, Subpart iii, Chapter 12, Section A - Neurological Conditions and Convulsive Disorders\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180519/M21-1-Part-V-Subpart-iii-Chapter-12-Section-A-Neurological-Conditions-and-Convulsive-Disorders\">M21-1, Part V, Subpart iii, 12.A</a>.</span></span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.2.i<a id=\"2i\" name=\"2i\">.</a> Ophthalmological Complications of Diabetes Mellitus</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Diabetic ophthalmological complications are largely due to blood vessel damage caused by high blood sugars such as leakage (hemorrhage) and/or blood vessel blockage.  The table below contains a description of diabetic eye complications.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"Column 1 provides diabetic eye complications and column 2 provides a description.\" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 258px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Diabetic Eye Complications</strong></span></span></span></span></div></th><th scope=\"col\" style=\"width: 252px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Description</strong></span></span></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 258px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">diabetic retinopathy</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">impairment or loss of vision due to damage affecting blood vessels of the retina</span></span></span></span></div></td></tr><tr><td style=\"width: 258px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">cataract</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">clouding or opaqueness of the lens of the eye</span></span></span></span></div></td></tr><tr><td style=\"width: 258px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">glaucoma</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">increased fluid pressure in the eye, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">causes loss of visual fields due to optic nerve damage</span></span></span></span></div></li></ul></td></tr></tbody></table><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on ophthalmological complications, see</span></span></span></span></div><ul><li><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000014461\" articlename=\"M21-1, Part V, Subpart iii, Chapter 2, Section A - Conditions of the Eyes\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014461/M21-1-Part-V-Subpart-iii-Chapter-2-Section-A-Conditions-of-the-Eyes\">M21-1, Part V, Subpart iii, 2.A</a>, and</span></span> </span></span></li><li><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=1&amp;SID=f4fc5b9f32005906d099c84f3082247e&amp;ty=HTML&amp;h=L&amp;r=SECTION&amp;n=se38.1.4_179\" target=\"_blank\">38 CFR 4.79</a>.</span></span> </span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.2.j<a id=\"2j\" name=\"2j\">.</a> Genitourinary Complications of Diabetes Mellitus</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Diabetic nephropathy is a common diabetic genitourinary complication of diabetes mellitus and may be rated based on criteria including</span></span></span></span></p><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">renal dysfunction, if renal function is affected</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">voiding dysfunction, if there is incontinence from autonomic nephropathy</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">urinary tract infection, if there is chronic pyelonephritis, as appropriate</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">kidney transplant</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">hemodialysis, or</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">nephrectomy. </span></span></span></span></div></li></ul><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  Erectile dysfunction (impotence/retrograde ejaculation) is another common complication of diabetes mellitus.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on genitourinary complications and potential entitlement to special monthly compensation (SMC), see</span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000180593\" articlename=\"M21-1, Part V, Subpart iii, Chapter 7 - Genitourinary Disabilities\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180593/M21-1-Part-V-Subpart-iii-Chapter-7-Genitourinary-Disabilities\">M21-1, Part V, Subpart iii, 7</a></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000177480\" articlename=\"M21-1, Part VIII, Subpart iv, Chapter 4, Section A - Special Monthly Compensation (SMC)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000177480/M21-1-Part-VIII-Subpart-iv-Chapter-4-Section-A-Special-Monthly-Compensation-SMC\">M21-1, Part VIII, Subpart iv, 4.A</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=707784593c29000a1d05368fb3bb539c&amp;node=se38.1.4_1115a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.115a</a>, and </span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&amp;SID=4884759b5f4da6fd92ceacc8ab21e2f9&amp;mc=true&amp;r=SECTION&amp;n=se38.1.4_1115b\" target=\"_blank\">38 CFR 4.115b</a>.</span></span></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.2.k<a id=\"2k\" name=\"2k\">.</a> Musculoskeletal Complications of Diabetes Mellitus</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Diabetic musculoskeletal complications affect the feet, ankles, bones, extremities, and overall gait.  The table below contains a description of diabetic musculoskeletal complications.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"Column 1 provides diabetic musculoskeletal complications and column 2 provides a description.\" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 258px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Diabetic Musculoskeletal Complications</strong></span></span></span></span></div></th><th scope=\"col\" style=\"width: 252px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Description</strong></span></span></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 258px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">foot complications</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">affects muscles, joints, and bones</span></span></span></span></div></td></tr><tr><td style=\"width: 258px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">foot neuropathic ulcers</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">results from abnormal pressure and lack of sensitivity to pain</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">leads to callus formation, osteomyelitis, and/or gangrene</span></span></span></span></div></li></ul></td></tr><tr><td style=\"width: 258px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">abnormalities of gait</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">sensory ataxia to include loss of balance and poor muscle coordination due to loss of position sense</span></span></span></span></div></td></tr><tr><td style=\"width: 258px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Charcot joints (neuropathic osteoarthropathy)</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">degenerative changes</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">instability, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">possible fragmentation of bones, particularly bones of the feet and ankles</span></span></span></span></div></li></ul></td></tr><tr><td style=\"width: 258px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">amputations</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">extremities, or</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">parts of extremities</span></span></span></span></div></li></ul></td></tr></tbody></table><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on musculoskeletal disabilities, see</span></span></span></span></div><ul><li><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000014407\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section A - Painful Motion and Functional Loss\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014407/M21-1-Part-V-Subpart-iii-Chapter-1-Section-A-Painful-Motion-and-Functional-Loss\">M21-1, Part V, Subpart iii, 1</a></span> </span></span></span></li><li><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=1&amp;SID=abf6b94acdb88dcd10e4cbb09801fb4c&amp;ty=HTML&amp;h=L&amp;r=SECTION&amp;n=se38.1.4_171a\" target=\"_blank\">38 CFR 4.71a</a>, and </span></span></span></span></span></li><li><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=1&amp;SID=abf6b94acdb88dcd10e4cbb09801fb4c&amp;ty=HTML&amp;h=L&amp;r=SECTION&amp;n=se38.1.4_173\" target=\"_blank\">38 CFR 4.73</a>.</span></span> </span></span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"height: 85px; width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.2.l<a id=\"2l\" name=\"2l\">.</a> Immune and Other Miscellaneous Complications of Diabetes Mellitus</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"height: 85px; width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Hyperglycemia causes the white blood cells of the immune system to function poorly.  In addition, all of the body's fluids have higher levels of sugar and nutrients, which make them more inviting for bacteria to grow and multiply.  This causes infections to be more serious and difficult to cure.  The table below contains a description of diabetic immune and other miscellaneous complications.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" spellcheck=\"false\" style=\"border-spacing: 1px; border-collapse: revert;\" summary=\"Column 1 provides diabetic immune and other miscellaneous complications, column 2 provides a description, and column 3 provides references.\"><thead><tr><th scope=\"col\" style=\"width: 193px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Diabetic Immune and Other Miscellaneous Complications</strong></span></span></span></span></div></th><th scope=\"col\" style=\"width: 252px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Description</strong></span></span></span></span></div></th><th scope=\"col\" style=\"width: 193px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>References</strong></span></span></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 193px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">malignant external otitis</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">a bacterial infection in older patients that causes</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">severe ear pain</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">necrosis of the external auditory canal, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">fever, and may also cause</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">paralysis of the facial nerve </span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">paralysis of other cranial nerves, and osteomyelitis of the base of the skull</span></span></span></span></div></li></ul></td><td style=\"width: 193px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000014464\" articlename=\"M21-1, Part V, Subpart iii, Chapter 2, Section B - Conditions of the Auditory System\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014464/M21-1-Part-V-Subpart-iii-Chapter-2-Section-B-Conditions-of-the-Auditory-System\">M21-1, Part V, Subpart iii, 2.B</a>, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=aee3a09b2de7f04436d9b078d17d0779&amp;node=se38.1.4_187&amp;rgn=div8\" target=\"_blank\">38 CFR 4.87</a>.</span></span></span></span></div></li></ul></td></tr><tr><td style=\"width: 193px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">nasopharyngeal mucormycosis</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">a rare and serious fungal infection, which usually develops during or following an episode of diabetic ketoacidosis</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">sudden onset with periorbital edema, pain, bloody nasal discharge, and increased lacrimation (tearing), and </span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">nasal mucosa and underlying tissues become black and necrotic</span></span></span></span></div></li></ul></td><td style=\"width: 193px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000180967\" articlename=\"M21-1, Part V, Subpart iii, Chapter 4, Section A - Respiratory Conditions\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180967/M21-1-Part-V-Subpart-iii-Chapter-4-Section-A-Respiratory-Conditions\">M21-1, Part V, Subpart iii, 4.A</a>, and </span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=aee3a09b2de7f04436d9b078d17d0779&amp;node=se38.1.4_197&amp;rgn=div8\" target=\"_blank\">38 CFR 4.97</a>.</span></span></span></span></div></li></ul></td></tr><tr><td style=\"width: 193px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">emphysematous cholecystitis</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">begins as an attack of biliary colic, which rapidly progresses, and </span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">recognized by x-rays that show gas in or around the gallbladder</span></span></span></span></div></li></ul></td><td style=\"width: 193px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000014523\" articlename=\"M21-1, Part V, Subpart iii, Chapter 6 - Digestive Disabilities\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014523/M21-1-Part-V-Subpart-iii-Chapter-6-Digestive-Disabilities\">M21-1, Part V, Subpart iii, 6</a>, and </span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=aee3a09b2de7f04436d9b078d17d0779&amp;node=se38.1.4_1114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.114</a>.</span></span></span></span></div></li></ul></td></tr><tr><td style=\"width: 193px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">emphysematous pyelonephritis</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">begins as an attack of biliary colic, which rapidly progresses, and </span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">recognized by x-rays that show gas in the kidney area</span></span></span></span></div></li></ul></td><td style=\"width: 193px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000180593\" articlename=\"M21-1, Part V, Subpart iii, Chapter 7 - Genitourinary Disabilities\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180593/M21-1-Part-V-Subpart-iii-Chapter-7-Genitourinary-Disabilities\">M21-1, Part V, Subpart iii, 7</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=aee3a09b2de7f04436d9b078d17d0779&amp;node=se38.1.4_1115a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.115a</a>, and </span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=aee3a09b2de7f04436d9b078d17d0779&amp;node=se38.1.4_1115b&amp;rgn=div8\" target=\"_blank\">38 CFR 4.115b</a>.</span></span></span></span></div></li></ul></td></tr><tr><td style=\"width: 193px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">vaginal infection</span></span></span></span></div></td><td style=\"width: 252px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">an inflammation of the vagina that creates discharge, odor, irritation, or itching</span></span></span></span></div></td><td style=\"width: 193px; padding: 1px;\"><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000180511\" articlename=\"M21-1, Part V, Subpart iii, Chapter 8, Section A - Disabilities of the Gynecological System\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180511/M21-1-Part-V-Subpart-iii-Chapter-8-Section-A-Disabilities-of-the-Gynecological-System\">M21-1, Part V, Subpart iii, 8.A</a>, and </span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=aee3a09b2de7f04436d9b078d17d0779&amp;node=se38.1.4_1116&amp;rgn=div8\" target=\"_blank\">38 CFR 4.116</a>.</span></span></span></span></div></li></ul></td></tr><tr><td style=\"width: 193px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">urinary tract infection</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">infection in any part of the urinary system including kidneys, ureters, bladder, and urethra, or </span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">a burning sensation, abdominal pain, and frequency in urination</span></span></span></span></div></li></ul></td><td style=\"width: 193px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000180593\" articlename=\"M21-1, Part V, Subpart iii, Chapter 7 - Genitourinary Disabilities\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180593/M21-1-Part-V-Subpart-iii-Chapter-7-Genitourinary-Disabilities\">M21-1, Part V, Subpart iii, 7</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=aee3a09b2de7f04436d9b078d17d0779&amp;node=se38.1.4_1115a&amp;rgn=div8\" target=\"_blank\">38 CFR 4.115a</a>, and </span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=aee3a09b2de7f04436d9b078d17d0779&amp;node=se38.1.4_1115b&amp;rgn=div8\" target=\"_blank\">38 CFR 4.115b</a>.</span></span></span></span></div></li></ul></td></tr><tr><td style=\"width: 193px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">oral thrush</span></span></span></span></div></td><td style=\"width: 252px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">a yeast infection of the tongue, inner cheek, lip, or gums</span></span></span></span></div></td><td style=\"width: 193px; padding: 1px;\"><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000014523\" articlename=\"M21-1, Part V, Subpart iii, Chapter 6 - Digestive Disabilities\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014523/M21-1-Part-V-Subpart-iii-Chapter-6-Digestive-Disabilities\">M21-1, Part V, Subpart iii, 6</a>, and </span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=aee3a09b2de7f04436d9b078d17d0779&amp;node=se38.1.4_1114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.114</a>.</span></span></span></span></div></li></ul></td></tr><tr><td style=\"width: 193px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">moniliasis</span></span></span></span></div></td><td style=\"width: 252px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">yeast infections affecting moist areas of the skin</span></span></span></span></div></td><td style=\"width: 193px; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a articleid=\"554400000180515\" articlename=\"M21-1, Part V, Subpart iii, Chapter 10 - Skin Conditions\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180515/M21-1-Part-V-Subpart-iii-Chapter-10-Skin-Conditions\">M21-1, Part V, Subpart iii, 10</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-family: Arial, Helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=fe0e68300be79a66a90fcd1efc477aa4&amp;mc=true&amp;node=se38.1.4_1118&amp;rgn=div8\" target=\"_blank\">38 CFR 4.118</a></span></span></span></span><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">.</span></span></span></span></div></li></ul></td></tr><tr><td style=\"width: 193px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">gastroparesis (paralysis of the stomach)</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">severe delayed gastric emptying (sometimes with dumping syndrome) due to vagus nerve involvement, and possible </span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">nausea, vomiting, early fullness in the stomach, bloating, abdominal pain, and weight loss</span></span></span></span></div></li></ul></td><td style=\"width: 193px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000014523\" articlename=\"M21-1, Part V, Subpart iii, Chapter 6 - Digestive Disabilities\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014523/M21-1-Part-V-Subpart-iii-Chapter-6-Digestive-Disabilities\">M21-1, Part V, Subpart iii, 6</a>, and </span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=aee3a09b2de7f04436d9b078d17d0779&amp;node=se38.1.4_1114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.114</a></span></span></span></span></div></li></ul></td></tr></tbody></table><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.2.m<a id=\"2m\" name=\"2m\">.</a> Skin Complications of Diabetes Mellitus</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Diabetes mellitus may result in skin complications.  The table below contains a description of diabetic skin complications.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"Column 1 provides diabetic skin complications and column 2 provides a description.\" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 258px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Diabetic Skin Complications</strong></span></span></span></span></div></th><th scope=\"col\" style=\"width: 252px; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Description</strong></span></span></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 258px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">candida</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">fungal infection, specifically a yeast infection in moist areas</span></span></span></span></div></td></tr><tr><td style=\"width: 258px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">dermatophytes</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">a group of three types of fungus causing superficial infections of the skin, hair, and nails</span></span></span></span></div></td></tr><tr><td style=\"width: 258px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">ulcers</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">sores on the skin to include disintegration of tissue</span></span></span></span></div></td></tr><tr><td style=\"width: 258px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">necrobiosis lipoidica diabeticorum</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">plaque-like yellow to brown lesions over the anterior tibial surfaces of the legs that may ulcerate</span></span></span></span></div></td></tr><tr><td style=\"width: 258px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">diabetic dermopathy</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">“shin spots” or small plaques with a raised border, also usually over the anterior tibial surfaces that may also ulcerate</span></span></span></span></div></td></tr><tr><td style=\"width: 258px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">bullosis diabeticorum</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">blisters spontaneously appearing on the hands or feet that heal in two to five weeks, sometimes with scarring and atrophy</span></span></span></span></div></td></tr><tr><td style=\"width: 258px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">atrophy of fatty tissue or skin thickening</span></span></span></span></div></td><td style=\"width: 252px; padding: 1px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">resulting from insulin injections</span></span></span></span></div></td></tr></tbody></table><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em> </em></strong></span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on skin disabilities, see</span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000180515\" articlename=\"M21-1, Part V, Subpart iii, Chapter 10 - Skin Conditions\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180515/M21-1-Part-V-Subpart-iii-Chapter-10-Skin-Conditions\">M21-1, Part V, Subpart iii, 10</a>, and</span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=1&amp;SID=abf6b94acdb88dcd10e4cbb09801fb4c&amp;ty=HTML&amp;h=L&amp;r=SECTION&amp;n=se38.1.4_1118\" target=\"_blank\">38 CFR 4.118</a>.</span></span></span></span></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/><br/><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><h2 class=\"ng-scope\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 16px\"><strong><span style=\"font-family: arial , helvetica , sans-serif\">3<a id=\"3\" name=\"3\">.</a>  Thyroid Conditions</span></strong></span></span></span></h2><p class=\"ng-scope\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 16px\"><strong><span style=\"font-family: arial , helvetica , sans-serif\">   </span></strong></span></span></span></p><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Introduction</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This topic contains information about thyroid conditions, including</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3a\" target=\"_self\">definitions of hyper- and hypothyroidism</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3b\" target=\"_self\">evaluating thyroid disabilities after the initial diagnosis</a></span></span></span></span></div></li><li><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3c\" target=\"_self\">rating thyroid enlargement, nontoxic</a></span></span> </span></span></li><li><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3d\" target=\"_self\">definition of myxedema</a>, and</span></span> </span></span></li><li><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#3e\" target=\"_self\">changes in the endocrine rating schedule</a>.</span></span> </span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Change Date</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">December 11, 2017</span></span></span></span></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.3.a<a id=\"3a\" name=\"3a\">.</a>  Definitions:  Hyper- and Hypothyroidism</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Hyperthyroidism (over-active thyroid)</em></strong> is a disorder where the thyroid gland synthesizes or creates excessive amounts of thyroid hormone.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  This condition may also be diagnosed as Graves’ disease.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Hypothyroidism</em></strong> <strong><em>(under-active thyroid)</em></strong> is a disorder where the thyroid gland does not produce enough thyroid hormone.</span></span></span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.3.b<a id=\"3b\" name=\"3b\">.</a>  Evaluating Thyroid Disabilities After the Initial Diagnosis</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When a thyroid DC calls for an initial evaluation, the initial evaluation, by its very nature, is not considered static.  Most symptoms of these conditions are alleviated within the initial period of treatment. </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">When the rating schedule requires the assignment of an evaluation for a specified period after the initial diagnosis, establish the initial evaluation for any applicable period for which the Veteran is eligible; and thereafter, evaluate based on residuals of the disease in the affected body system(s) as directed by the relevant DC.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Notes</em></strong>: </span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">In cases where the claim is being decided during the initial evaluation period, establish controls for a review exam at the end of that period to determine the appropriate evaluation.</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">For any complications shown on the review examination, follow the procedures in <a articleid=\"554400000014324\" articlename=\"M21-1, Part IV, Subpart ii, Chapter 2, Section A - Rating Action on Review Examination Results and Cancellations\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014324/M21-1-Part-IV-Subpart-ii-Chapter-2-Section-A-Rating-Action-on-Review-Examination-Results-and-Cancellations\">M21-1, Part IV, Subpart ii, 2.A.1.b</a> for awarding benefits for residuals of the primary SC disability.</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If treatment for one form of thyroid dysfunction causes a new diagnosis of the other form of thyroid dysfunction, the Veteran is entitled to an initial evaluation for the newly diagnosed thyroid disease. </span></span></span></span></div></li></ul><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">establishing future exam control, see <a articleid=\"554400000014904\" articlename=\"M21-1, Part IV, Subpart ii, Chapter 1, Section B - Control of Future Examinations\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014904/M21-1-Part-IV-Subpart-ii-Chapter-1-Section-B-Control-of-Future-Examinations\">M21-1, Part IV, Subpart ii, 1.B</a></span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">static disabilities, see</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000014553\" articlename=\"M21-1, Part IV, Subpart ii, Chapter 2, Section B - Failure to Report for Review Examinations\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014553/M21-1-Part-IV-Subpart-ii-Chapter-2-Section-B-Failure-to-Report-for-Review-Examinations\">M21-1, Part IV, Subpart ii, 2.B.2.b</a>, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000180489\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section D - Evaluating Disabilities\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180489/M21-1-Part-V-Subpart-ii-Chapter-3-Section-D-Evaluating-Disabilities\">M21-1, Part V, Subpart ii, 3.D.4</a>, and</span></span></span></span></div></li></ul></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">evaluations of thyroid disabilities, see <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=9c5318ab5105f2186790fb547cd58160&amp;mc=true&amp;node=se38.1.4_1119&amp;rgn=div8\" target=\"_blank\">38 CFR 4.119</a>.</span></span></span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.3.c<a id=\"3c\" name=\"3c\">.</a>  Rating Thyroid Enlargement, Nontoxic</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">In the context of thyroid function, <em><strong>nontoxic</strong></em> means that thyroid function is normal. Because thyroid function is normal, the disabling effects of nontoxic thyroid enlargement are generally either manifest as disfigurement or a result of pressure on adjacent organs (such as trachea, larynx, or esophagus). Evaluate this condition based on one or both of these effects, if present. </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><em><strong>Reference</strong></em>: For more information on evaluating thyroid enlargement, nontoxic, see <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=b264edc4c4be624457329ecb8dde0ef0&amp;mc=true&amp;node=se38.1.4_1119&amp;rgn=div8\" target=\"_blank\">38 CFR 4.119, DC 7902</a>.</span></span></span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.3.d<a id=\"3d\" name=\"3d\">.</a>  Definition: Myxedema</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Myxedema</em></strong> (coma or crisis) is a life-threatening form of hypothyroidism found predominantly in undiagnosed or undertreated individuals that requires inpatient hospitalization for stabilization. </span></span></span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.11.3.e<a id=\"3e\" name=\"3e\">.</a>  Changes in the Endocrine Rating Schedule </span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">On December 10, 2017, VA implemented changes in the rating criteria under <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=9c5318ab5105f2186790fb547cd58160&amp;mc=true&amp;node=se38.1.4_1119&amp;rgn=div8\" target=\"_blank\">38 CFR 4.119</a>.  These changes should not be the basis of a reduction in a Veteran’s disability rating unless medical evidence establishes that the disability has actually improved.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">   </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Note</em></strong>:  These changes in the rating criteria are not considered liberalizing.</span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></span></span></div><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the effect of a rating schedule readjustment, see</span></span></span></span></div><ul><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=5d96e7936d7459d82a92a94ac1914e7b&amp;mc=true&amp;node=se38.1.3_1951&amp;rgn=div8\" target=\"_blank\">38 CFR 3.951</a>, and</span></span></span></span></div></li><li><div><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000180489\" articlename=\"M21-1, Part V, Subpart ii, Chapter 3, Section D - Evaluating Disabilities\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180489/M21-1-Part-V-Subpart-ii-Chapter-3-Section-D-Evaluating-Disabilities\">M21-1, Part V, Subpart ii, 3.D.2.i</a>, and</span></span></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">applying new rating schedule criteria to increased rating claims, see <a articleid=\"554400000180492\" articlename=\"M21-1, Part V, Subpart ii, Chapter 4, Section A - Effective Dates\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180492/M21-1-Part-V-Subpart-ii-Chapter-4-Section-A-Effective-Dates\">M21-1, Part V, Subpart ii, 4.A.6.m</a>.</span></span></div></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/></div><p class=\"ng-scope\"></p><h2 class=\"ng-scope\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>4<a id=\"4\" name=\"4\">.</a>  Examples of Rating Decisions Involving the Complications of Diabetes Mellitus</strong></span></span></span></span></h2><p class=\"ng-scope\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong> </strong></span></span></span></span></p><p class=\"ng-scope\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong> </strong></span></span></span></span></p><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></span></span></p></td><td style=\"width: 516px; padding: 0px;\"><p><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">This topic contains three examples of rating decisions involving the complications of diabetes mellitus, including</span></span></span></span></p><ul><li><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#4a\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">example 1 of a rating decision involving complications of diabetes mellitus</span></span></a> </span></span></li><li><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"#4b\" target=\"_self\">example 2 of a rating decision involving complications of diabetes mellitus</a>, and</span></span> </span></span></li><li><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"#4c\" target=\"_self\">example 3 of a rating decision involving complications of diabetes mellitus</a>.</span></span> </span></span></li></ul></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" spellcheck=\"false\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></strong></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">December 13, 2005</span></span></span></span></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.11.4.a<a id=\"4a\" name=\"4a\"></a>.  Example 1: Rating Decision Involving Complications of Diabetes Mellitus</span></span></span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Situation</em></strong>:  The Veteran has noncompensable complications of diabetes mellitus but does not have ketoacidosis or hypoglycemic reactions.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">  </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Result</em></strong>:  Do not evaluate the diabetes mellitus at 60 percent simply because noncompensable complications are present.  Assign a 40-percent evaluation if there is a requirement of insulin, restricted diet, and regulation of activities.  Include the noncompensable complications under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=ff0446622e8f862b4088917492918417&amp;node=se38.1.4_1119&amp;rgn=div8\" target=\"_blank\">38 CFR 4.119, DC 7913</a>.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.11.4.b<a id=\"4b\" name=\"4b\"></a>.  Example 2: Rating Decision Involving Complications of Diabetes Mellitus</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Situation</em></strong>:  The Veteran’s diabetes mellitus is controlled by insulin, restricted diet, and regulation of activities.  In addition, there is diabetic peripheral neuropathy compensable at 10 percent. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">  </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Result</em></strong>:  Rate the diabetes mellitus at 40 percent and separately evaluate the compensable complication of diabetic peripheral neuropathy in accordance with the note under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=ff0446622e8f862b4088917492918417&amp;node=se38.1.4_1119&amp;rgn=div8\" target=\"_blank\">38 CFR 4.119, DC 7913</a>.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.11.4.c<a id=\"4c\" name=\"4c\" spellcheck=\"false\"></a>.  Example 3: Rating Decision Involving Complications of Diabetes Mellitus</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Situation</em></strong>:  The Veteran underwent a below-the-knee amputation due to complications of diabetes mellitus.  In addition</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">his diabetes mellitus requires</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">more than one daily injection of insulin</span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">restricted diet, and</span></span></span></span></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">regulation of activities</span></span></span></span></span></span></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">his episodes of ketoacidosis require weekly visits to the diabetic care provider, but</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">there is no progressive loss of weight and strength.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Result</em></strong>:  Evaluate the diabetes mellitus at 100 percent and award SMC (k) for anatomical loss of a foot.  Since the below-the-knee amputation is secondary to diabetes mellitus, and is considered a compensable complication (in lieu of progressive loss of weight and strength), to warrant the 100-percent evaluation, it would be pyramiding to assign a separate 40-percent evaluation for the amputation.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">  </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  If compensable complications are not considered in reaching the 100- percent evaluation, they may be separately evaluated.</span></span></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><p class=\"ng-scope\" style=\"text-align: right\"><a articleid=\"554400000180515\" articlename=\"M21-1, Part V, Subpart iii, Chapter 10 - Skin Conditions\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180515/M21-1-Part-V-Subpart-iii-Chapter-10-Skin-Conditions\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\">&lt;-- Previous Section</span></span></a><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\">   <a articleid=\"554400000180519\" articlename=\"M21-1, Part V, Subpart iii, Chapter 12, Section A - Neurological Conditions and Convulsive Disorders\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180519/M21-1-Part-V-Subpart-iii-Chapter-12-Section-A-Neurological-Conditions-and-Convulsive-Disorders\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\">Next Section --&gt;</span></span></a></span></span></p><p class=\"ng-scope\"><span style=\"font-size: 11px\"><span style=\"font-family: arial, helvetica, sans-serif\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#top\" target=\"_self\"><span style=\"font-size: 11px\">To Top</span></a></span></span></span></p><p class=\"ng-scope\"></p></div>\n</div>",
  "external_links": [
    "http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=&SID=4884759b5f4da6fd92ceacc8ab21e2f9&mc=true&r=SECTION&n=se38.1.4_1115b",
    "http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=1&SID=abf6b94acdb88dcd10e4cbb09801fb4c&ty=HTML&h=L&r=SECTION&n=se38.1.4_1118",
    "http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=1&SID=abf6b94acdb88dcd10e4cbb09801fb4c&ty=HTML&h=L&r=SECTION&n=se38.1.4_171a",
    "http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=1&SID=abf6b94acdb88dcd10e4cbb09801fb4c&ty=HTML&h=L&r=SECTION&n=se38.1.4_173",
    "http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=1&SID=f4fc5b9f32005906d099c84f3082247e&ty=HTML&h=L&r=SECTION&n=se38.1.4_1104",
    "http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=1&SID=f4fc5b9f32005906d099c84f3082247e&ty=HTML&h=L&r=SECTION&n=se38.1.4_179",
    "http://www.ecfr.gov/cgi-bin/retrieveECFR?gp=2&SID=f4fc5b9f32005906d099c84f3082247e&ty=HTML&h=L&r=SECTION&n=se38.1.4_114",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=46329ddeee04ec59e533ad235a9cf52e&mc=true&node=se38.1.3_1155&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=66ebdb01f4461c9b7dd53fbd1eb989cb&mc=true&node=se38.1.3_1400&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=707784593c29000a1d05368fb3bb539c&node=se38.1.4_1115a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=7941a3130baebed52275ce222d379779&mc=true&node=se38.1.3_1655&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=aee3a09b2de7f04436d9b078d17d0779&node=se38.1.4_1114&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=aee3a09b2de7f04436d9b078d17d0779&node=se38.1.4_1115a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=aee3a09b2de7f04436d9b078d17d0779&node=se38.1.4_1115b&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=aee3a09b2de7f04436d9b078d17d0779&node=se38.1.4_1116&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=aee3a09b2de7f04436d9b078d17d0779&node=se38.1.4_1124a&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=aee3a09b2de7f04436d9b078d17d0779&node=se38.1.4_187&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=aee3a09b2de7f04436d9b078d17d0779&node=se38.1.4_197&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=e2f73f1caf49a1d2a2c8556e7cedb991&mc=true&node=se38.1.3_1114&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=fe0e68300be79a66a90fcd1efc477aa4&mc=true&node=se38.1.4_1118&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=ff0446622e8f862b4088917492918417&node=se38.1.4_1119&rgn=div8",
    "http://www.gpo.gov/fdsys/pkg/CFR-2014-title38-vol1/pdf/CFR-2014-title38-vol1-sec3-157.pdf",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=578da4e1b9e5912d873a7d6fcd7b8ae3&mc=true&node=se38.1.3_1155&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=5d96e7936d7459d82a92a94ac1914e7b&mc=true&node=se38.1.3_1951&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=9c14819d0bc041f9805b8b177bac2dee&mc=true&node=se38.1.3_1326&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=9c5318ab5105f2186790fb547cd58160&mc=true&node=se38.1.4_1119&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=b264edc4c4be624457329ecb8dde0ef0&mc=true&node=se38.1.4_1119&rgn=div8"
  ],
  "scraped_at": "2025-06-16T22:45:53.885996",
  "next_section": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180519/M21-1-Part-V-Subpart-iii-Chapter-12-Section-A-Neurological-Conditions-and-Convulsive-Disorders"
}